Abdullah Alshammaa, MD
Neurology · Loma Linda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 23
Offices
23 locations · Faculty Physicians and Surgeons of Llusm · Cep America - Neurology PC
Looking this up.
Hospitals listed: Adventist Health and Rideout · El Camino Health · Sharp Chula Vista Medical Center · St Michael Medical Center · Temecula Valley Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alshammaa’s office to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health and RideoutMarysville, CAAcute Care Hospital · Government - Federal · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 52% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.185, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.278, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Sharp Chula Vista Medical CenterChula Vista, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Sharp Healthcare, which runs 6 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.283, Oct 2024 – Sep 2025
- St Michael Medical CenterSilverdale, WAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.269, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.413, Oct 2024 – Sep 2025
- Temecula Valley HospitalTemecula, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Universal Health Services, which runs 158 hospitals in 38 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.519, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health and Rideout
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.278 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.39 (0.38 to 2.39) · 1,014 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.57 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.11 (154.04 to 248.18) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.9 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 229 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 255 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.1 · 713 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 660 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.2 · 265 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,347 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 7,148 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.09 to 0.48) · 7,390 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.77 (1.69 to 5.85) · 1,259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.23) · 239 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (1.01 to 4.02) · 1,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.42 (0 to 15.26) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.32 (1.3 to 9.35) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.48 to 3.42) · 187 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.42 (0 to 1.02) · 6,712 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.246 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.644 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.447 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 211 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 694 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 38.3 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33.9 · 801 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43 · 665 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 617 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.6 to 8.9) · 213 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.9 (9.1 to 15.5) · 213 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.5) · 167 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.5) · 316 cases | No different | Jan 2024 – Dec 2024 |
What patients said (559 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 52% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sharp Chula Vista Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.283 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.35 (0.36 to 2.34) · 872 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.79 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 178.91 (128.64 to 229.19) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.3 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 412 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 490 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.2 · 364 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 4,213 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 6,145 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 6,385 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 6) · 1,111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.31 (0.68 to 3.94) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.54 to 3.59) · 958 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.99 (2.49 to 17.49) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 212 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.15 to 1.38) · 5,253 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 34 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.404 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.224 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 933 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.9 · 134 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.2 · 528 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 894 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.9) · 47 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 15.2) · 47 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 77 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 23.1 · 253 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.9 to 18.2) · 133 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 150 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,585 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Michael Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.269 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.413 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.78 (0.86 to 2.69) · 1,802 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.64 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.65 (121.82 to 213.47) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 235 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.6 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 771 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 715 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.1 · 412 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 4,690 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 9,144 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.6 (0.79 to 4.4) · 2,612 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.24 (0 to 2.56) · 1,077 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.98 (1.64 to 4.32) · 2,284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.5 (5.2 to 13.8) · 1,071 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.36 (2.49 to 8.23) · 1,091 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.5 (0.09 to 2.91) · 480 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 0.91) · 7,543 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 125 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.566 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.607 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 529 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.3 · 947 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.9 · 529 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20.5 · 822 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11.6 · 707 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 13.9 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (3.2 to 5.8) · 490 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (7.9 to 12.1) · 490 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 208 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 23.1 · 198 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.4) · 341 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.9 to 1.2) · 1,423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (728 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Temecula Valley Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.519 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 613 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.57 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.74 (113.19 to 218.29) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 288 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 274 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 2,704 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,867 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,044 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.37 (2.03 to 6.72) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0 to 3.26) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.21 (0.63 to 3.79) · 828 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.75 (0 to 15.76) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.74 (0.61 to 8.87) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.41) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 39 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.458 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.61 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.441 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.692 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 490 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 639 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.1 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.4 · 342 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1 · 296 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 521 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.1) · 31 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 176 cases | No different | Jan 2024 – Dec 2024 |
What patients said (914 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$34,195
Medicare paid this office $34,195 for 258 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 32 | $10,311 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $5,766 | $99 |
| Measurement of brain wave activity (eeg), awake and drowsy | 51 | $2,227 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,934 | $62 |
| Return visit (30+ min) | 22 | $1,393 | $63 |
See all 11 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 32 | $10,311 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $5,766 | $99 |
| Measurement of brain wave activity (eeg), awake and drowsy | 51 | $2,227 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,934 | $62 |
| Return visit (30+ min) | 22 | $1,393 | $63 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 12 | $1,113 | $93 |
| Measurement of brain wave activity (eeg), awake and asleep | 22 | $929 | $42 |
| New patient visit (45+ min) | 12 | $869 | $72 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $796 | $66 |
| Short return visit (20+ min) | 11 | $478 | $43 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 20 | $225 | $11 |
Who their Medicare patients are
258 Original Medicare patients in 2024. Average age 70 · Under 65 27% · 85 and older 14% · Women 50% · Also on Medicaid 46% · Health risk score 2.26. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Depression 49% · Diabetes 48% · Stroke 48% · Chronic kidney disease 43% · Coronary heart disease 35% · Heart failure 33% · Dementia 32% · Atrial fibrillation 27% · COPD 26% · Cancer 16%.
The office billed $111,509, Medicare allowed $46,008 and paid $34,195; for 385 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 258 | 385 | 70 | 2.26 | $111,509 | $34,195 |
| 2023 | 238 | 344 | 66 | 1.84 | $93,251 | $36,794 |
| 2022 | 402 | 697 | 72 | 2.46 | $255,492 | $59,685 |
| 2021 | 398 | 895 | 74 | 2.32 | $286,791 | $74,469 |
| 2020 | 85 | 215 | 73 | 2.24 | $64,261 | $19,993 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 21 | $5,459 | $152 |
| Return visit (30+ min) | 45 | $4,059 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,285 | $100 |
| Long return visit (40+ min) | 19 | $2,992 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $2,805 | $134 |
| New patient visit (45+ min) | 19 | $1,871 | $98 |
| New patient visit (60+ min) | 12 | $1,631 | $136 |
| Short return visit (20+ min) | 20 | $1,299 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,283 | $92 |
| Measurement of brain wave activity (eeg), awake and drowsy | 22 | $983 | $43 |
| Measurement of brain wave activity (eeg), awake and asleep | 13 | $555 | $43 |
| Measurement of brain wave activity (eeg), awake and asleep | 11 | $469 | $43 |
2022: 11 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 85 | $25,064 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $6,957 | $145 |
| Measurement of brain wave activity (eeg), awake and drowsy | 131 | $5,377 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,873 | $73 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 71 | $2,996 | $42 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 29 | $2,919 | $97 |
| Measurement of brain wave activity (eeg), awake and asleep | 55 | $2,303 | $41 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 25 | $1,586 | $61 |
| Return visit (30+ min) | 13 | $977 | $65 |
| Measurement of brain wave activity (eeg), in coma or asleep | 18 | $827 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $799 | $53 |
2021: 13 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 91 | $29,343 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $7,973 | $54 |
| Measurement of brain wave activity (eeg), awake and drowsy | 141 | $6,284 | $43 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 55 | $6,013 | $102 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $5,267 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,937 | $151 |
| Measurement of brain wave activity (eeg), awake and asleep | 89 | $3,925 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $1,710 | $74 |
| Measurement of brain wave activity (eeg), in coma or asleep | 34 | $1,531 | $41 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 21 | $1,405 | $67 |
| Return visit (30+ min) | 12 | $1,334 | $95 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,212 | $76 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 25 | $1,058 | $42 |
2020: 5 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 24 | $6,929 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,515 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,767 | $56 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 19 | $2,394 | $104 |
| Measurement of brain wave activity (eeg), awake and drowsy | 29 | $1,354 | $45 |
Medicaid work
$921 in 2024
Medicaid paid $921 for 15 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 15 | $921 |
| 2024 | 15 | 1 | 15 | $921 |
| 2022 | 194 | 5 | 30 | $6,382 |
| 2021 | 51 | 2 | 14 | $901 |
See the largest Medicaid services in earlier years
2022
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 71 | $3,712 |
| Electroencephalogram (EEG) extended monitoring; 41-60 minutes | 74 | $1,732 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $428 |
| Electroencephalogram (EEG); including recording awake and asleep | 13 | $261 |
| Electroencephalogram (EEG); including recording awake and drowsy | 20 | $248 |
2021
| Electroencephalogram (EEG); including recording awake and asleep | 32 | $634 |
| Electroencephalogram (EEG); including recording awake and drowsy | 19 | $267 |
Drugs they prescribed that Part D paid
$89,210
Pharmacies billed $89,210 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 469) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
385 generic and fewer than 11 brand-name prescriptions · $89,210 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Briviact | None | 15 | $20,789 | $1,386 |
| Emgality | Migraine | 22 | $14,899 | $677 |
| Ubrelvy | None | 11 | $10,798 | $982 |
| Lacosamide | None | 31 | $1,278 | $41 |
| Divalproex | None | 12 | $1,068 | $89 |
See all 16 drugs
| Briviact | None | 15 | $20,789 | $1,386 |
| Emgality | Migraine | 22 | $14,899 | $677 |
| Ubrelvy | None | 11 | $10,798 | $982 |
| Lacosamide | None | 31 | $1,278 | $41 |
| Divalproex | None | 12 | $1,068 | $89 |
| Levetiracetam | None | 18 | $1,054 | $59 |
| Topiramate | None | 34 | $774 | $23 |
| Zonisamide | None | 17 | $658 | $39 |
| Carbidopa-Levodopa | None | 15 | $625 | $42 |
| Primidone | None | 23 | $600 | $26 |
| Gabapentin | None | 30 | $571 | $19 |
| Tizanidine | None | 13 | $345 | $27 |
| Pregabalin | None | 38 | $309 | $8 |
| Lamotrigine | None | 24 | $272 | $11 |
| Donepezil | None | 23 | $254 | $11 |
| Memantine | None | 15 | $194 | $13 |
Year by year
| 2024 | 469 | 106 | 0% (0) | None | $89,210 |
| 2023 | 457 | 117 | None | 11% | $60,509 |
| 2022 | 178 | 27 | 0% (0) | 8% | $20,186 |
| 2021 | 75 | 20 | 0% (0) | None | $11,491 |
| 2020 | 30 | 11 | 0% (0) | None | $2,556 |
| 2019 | 124 | 30 | 0% (0) | None | $4,004 |
| 2018 | 207 | 61 | 0% (0) | 14% | $17,949 |
| 2017 | 195 | 53 | 0% (0) | 11% | $7,015 |
| 2016 | 239 | 61 | None | None | $11,086 |
| 2015 | 68 | 24 | None | None | $4,856 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Emgality | Migraine | 22 | $15,480 | $704 |
| Lacosamide | None | 33 | $4,987 | $151 |
| Carbidopa-Levodopa | None | 41 | $1,690 | $41 |
| Gabapentin | None | 67 | $1,345 | $20 |
| Levetiracetam | None | 27 | $947 | $35 |
| Divalproex | None | 13 | $877 | $67 |
| Topiramate | None | 20 | $660 | $33 |
| Amitriptyline | None | 21 | $321 | $15 |
| Phenobarbital | None | 11 | $310 | $28 |
| Donepezil | None | 44 | $279 | $6 |
| Rizatriptan | None | 11 | $209 | $19 |
| Pregabalin | None | 11 | $107 | $10 |
2022: 3 drugs
| Levetiracetam | 74 | $4,128 | $56 |
| Lamotrigine | 48 | $403 | $8 |
| Zonisamide | 16 | $366 | $23 |
2021: 2 drugs
| Levetiracetam | 26 | $954 | $37 |
| Lamotrigine | 15 | $182 | $12 |
2019: 2 drugs
| Gabapentin | 11 | $243 | $22 |
| Tizanidine | 16 | $194 | $12 |
2018: 5 drugs
| Carbidopa-Levodopa | 15 | $520 | $35 |
| Levetiracetam | 30 | $275 | $9 |
| Atorvastatin | 22 | $246 | $11 |
| Donepezil | 20 | $176 | $9 |
| Gabapentin | 16 | $166 | $10 |
2017: 4 drugs
| Carbidopa-Levodopa | 29 | $668 | $23 |
| Donepezil | 16 | $487 | $30 |
| Atorvastatin | 41 | $381 | $9 |
| Amlodipine Besylate | 17 | $90 | $5 |
2016: 3 drugs
| Atorvastatin | 46 | $490 | $11 |
| Amlodipine Besylate | 15 | $117 | $8 |
| Lisinopril | 12 | $49 | $4 |
Money from drug and device companies
$19 in 2025
| 2025 | 1 | 1 | None | $19 |
| 2024 | 4 | 5 | None | $118 |
| 2023 | 9 | 18 | None | $718 |
| 2022 | 2 | 2 | None | $137 |
| 2021 | 2 | 3 | None | $235 |
| 2020 | 1 | 1 | None | $20 |
| 2019 | 1 | 2 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Celgene | Zeposia | $19 | 1 payment
|
See the published payment
| Celgene | Meals · 2025-03-20 | Zeposia | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $118
| Ucb | Briviact | $66 | 2 payments
|
| Eisai | Leqembi | $19 | 1 payment
|
| Boston Scientific | None | $19 | 1 payment
|
| Celgene | Zeposia | $13 | 1 payment
|
2023: $718
| Ucb | Briviact | $270 | 9 payments
|
| Neurelis | Valtoco | $194 | 2 payments
|
| Neuropace | Rns Neurostimulator Kit | $152 | 1 payment
|
| SK Life Science | None | $19 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $19 | 1 payment
|
| Lilly USA | Emgality | $18 | 1 payment
|
| Celgene | Zeposia | $16 | 1 payment
|
| Genentech USA | Enspryng | $16 | 1 payment
|
| AbbVie | Botox | $15 | 1 payment
|
2022: $137
| Ucb | Briviact | $110 | 1 payment
|
| SK Life Science | None | $27 | 1 payment
|
2021: $235
| LivaNova USA | Vns - Sentiva | $136 | 1 payment
|
| SK Life Science | None | $99 | 2 payments
|
2020: $20
| Supernus Pharmaceuticals | Oxtellar Xr | $20 | 1 payment
|
2019: $142
| Eisai | Fycompa | $142 | 2 payments
|
Professional record
- NPI
- 1073908869
- Licence
- MI 4301507824
- Group
- Faculty Physicians and Surgeons of Llusm · Cep America - Neurology PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 11370 Anderson St Ste B100, Loma Linda, CA, 92354
- NPI first listed
- 2015-03-30
- NPI last updated
- 2026-02-17
- NPI record certified
- 2026-02-17
This is when the NPI record was last certified, not a medical board exam.